Obese mice whose fat cells were genetically altered to produce an increased amount of the glucose-dependent insulinotropic ...

Takeda and Orexigen have been given FDA clearance to market their obesity ... also be a new randomised double-blind, placebo-controlled study to evaluate the effects of long-term treatment with ...

The AAP issued guidelines delineating prevention and treatment of obesity in 2007, but the new recommendations are based on decades of evidence-based data on best practices for helping children ...

(Those are slightly higher shares than the estimate from the Center s for Disease Control and Prevention, which says around 40% of U.S. adults had obesity from 2021 ... at the New York University ...

Then her provider referred her to see physician assistant Cody Baxter in 2021 ... an obesity specialist, to see if he could recommend more helpful treatment. He steered her toward the new medications.

The number of new companies and drugs in development for both obesity and MASH treatment is staggering. It is nearly guaranteed that some number of firms will design similar Phase 3 obesity ...

Eli Lilly has launched a unique website to connect U.S. patients seeking obesity treatment to doctors, dieticians and its new weight-loss drug, Zepbound. The drugmaker said Thursday it will use ...